|
    MRNA U.S.: Nasdaq

    Moderna Inc.

    Watchlist
    NEW
    Set a price target alert
    MRNAUS
    After Hours
    Last Updated: Oct 3, 2023 7:58 p.m. EDT Delayed quote

    $ 102.78

    -0.30 -0.29%
    After Hours Volume: 101.58K
    Close Chg Chg %
    $103.08 -0.23 -0.22%
    Advanced Charting
    Volume: 2.42M 65 Day Avg: 3.82M
    63% vs Avg
    100.92 Day Range 103.68
    95.02 52 Week Range 217.25

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    MRNA Overview

    Key Data

    • Open $101.93
    • Day Range 100.92 - 103.68
    • 52 Week Range 95.02 - 217.25
    • Market Cap $39.32B
    • Shares Outstanding 380.59M
    • Public Float 330.92M
    • Beta 0.62
    • Rev. per Employee $2.706M
    • P/E Ratio 37.87
    • EPS $2.72
    • Yield N/A
    • Dividend N/A
    • Ex-Dividend Date N/A
    • Short Interest 18.16M 09/15/23
    • % of Float Shorted 5.49%
    • Average Volume 3.82M

    Performance

    5 Day
    • 3.66%
    1 Month
    • -4.77%
    3 Month
    • -16.56%
    YTD
    • -42.61%
    1 Year
    • -17.94%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 24 Full Ratings

    Recent News

    Read full story

    Moderna Inc. stock falls Tuesday, still outperforms market

    Read full story

    Novavax Stock Jumps After FDA Approves Updated Covid-19 Vaccine

    Read full story

    Novavax updated COVID vaccine gets FDA approval

    Read full story

    Moderna Inc. stock rises Monday, still underperforms market

    Read full story

    Scientists Whose Work Led to Covid mRNA Vaccines Receive Nobel Prize in Medicine

    Read full story

    Moderna Inc. stock outperforms market on strong trading day

    Read full story

    Moderna Inc. stock outperforms competitors on strong trading day

    Read full story

    Covid-19 Vaccine Uptake Could Beat Expectations, Poll Indicates

    Read full story

    Moderna Inc. stock outperforms market on strong trading day

    Read full story

    Wall Street analysts expect the S&P 500 to rise 19% over the next 12 months. Here are their 10 favorite stocks.

    Read full story

    Free Covid Tests Are Coming. Here’s How to Get Yours.

    Read full story

    Shutdown, Strikes, Sticky Inflation, and More… Brace for a Bumpy Fourth Quarter

    Read full story

    Have you gotten your shot? 5 things to know about the new COVID-19 vaccine.

    Read full story

    The Covid Booster Rollout Is a Mess. That’s Good News for Pfizer and Moderna.

    Read full story

    These Stocks Are Moving the Most Today: Instacart, Disney, NIO, Bausch Health, Enphase, U.S. Steel, Rocket Lab, and More

    Read full story

    New Cancer Drugs Are Changing the Odds. The Latest on Treatments.

    Read full story

    ‘This Is Not a Covid Vaccine Company,’ Moderna CEO Says

    Read full story

    U.S. stocks close mostly higher despite inflation edging up in August

    Read full story

    Moderna Rises on Positive Results From Flu Vaccine, and Other Plans to Move Beyond Covid

    Read full story

    Apple Stock, Adobe, Oracle, Moderna, Lennar, Inflation Data, and More to Watch This Week

    Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich

    on InvestorPlace.com

    Novavax Stock Soars On FDA Clearance For Updated Covid-19 Shot: What's Going On?

    on Benzinga.com

    Moderna Unusual Options Activity For October 03

    on Benzinga.com

    Is Pfizer Stock a Buy Now?

    on Motley Fool

    2 Top Biotech Stocks to Buy in October

    on Motley Fool

    The Zacks Analyst Blog Highlights Intel, Anheuser-Busch InBev, HCA Healthcare, Moderna and DuPont de Nemours

    on Zacks.com

    Developers of mRNA Vaccines Honored with Nobel Prize

    on TipRanks.com

    Top Stock Reports for Intel, Anheuser-Busch & HCA Healthcare

    on Zacks.com

    Have The Bulls Returned? Get Prepared For October And Q4 With Markets With Mando!

    on Benzinga.com

    Nobel Prize Honors Scientists Behind mRNA Vaccines Against Covid-19

    on Benzinga.com

    3 Revolutionary Stocks I'd Buy Right Now Without Hesitation

    on Motley Fool

    Moderna's Shares Could Take Off if These 2 Things Happen

    on Motley Fool

    Here's Why You Should Consider Moderna Stock, and No, It's Not the COVID Vaccine

    on Motley Fool

    Why Pfizer and BioNTech Stocks Zoomed Higher Today

    on Motley Fool

    10 Health Care Stocks With Whale Alerts In Today's Session

    on Benzinga.com

    If I Could Only Buy 3 Stocks in 2023, I'd Pick These

    on Motley Fool

    Is it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?

    on Zacks.com

    Moderna (MRNA) Outpaces Stock Market Gains: What You Should Know

    on Zacks.com

    Check Out What Whales Are Doing With MRNA

    on Benzinga.com

    Biden's Urgent Action Against Antibiotic-Resistant Bacteria - Allocates $100M to Battle Deadly Superbugs

    on Benzinga.com

    Moderna Inc.

    Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

    Competitors

    Name Chg % Market Cap
    Johnson & Johnson 0.12% $373.6B
    Pfizer Inc. -0.12% $191.62B
    AstraZeneca PLC ADR -0.73% $205.71B
    AstraZeneca PLC -0.20% £169.71B
    GSK PLC -0.55% £60.42B
    Gilead Sciences Inc. -1.12% $92.33B
    BioNTech SE ADR -3.03% $27.03B
    Regeneron Pharmaceuticals Inc. -1.19% $88.8B
    Biogen Inc. -0.61% $36.62B
    CureVac N.V. -1.72% $1.44B